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Resumo 
 
A saúde desempenha um papel inquestionável no bem-estar dos indivíduos e 
desenvolvimento dos países. No que toca à sua contribuição para o crescimento económico, 
existem, contudo, visões divergentes. Estas visões têm por base resultados de estimações 
que apenas consideram a influência da saúde sobre o valor médio das taxas de crescimento 
do produto/rendimento das amostras analisadas, ignorando a possibilidade de efeitos 
diversos dos regressores para diferentes valores da variável dependente. Ou seja, ignoram 
que a influência da saúde pode ser heterogénea dependendo da própria evolução da 
economia. A análise que desenvolvemos no presente trabalho, para uma amostra máxima de 
92 países respeitante ao período 1980-2010, comprova esta heterogeneidade. Com efeito, 
através da estimação de uma regressão de crescimento ad hoc onde aplicamos a metodologia 
de Canay (2011) para regressão por quantis (Koenker 2012a; Koenker 2012b), verificamos 
que variações na saúde têm um impacto positivo no crescimento económico e que esse 
impacto é maior para países com taxas de crescimento baixas. Estes resultados aplicam-se 
quando consideramos indicadores de saúde positivos (esperança média de vida, consumo de 
calorias diário por pessoa) e negativos (taxa de mortalidade infantil e taxa de subnutrição). 
Destes concluímos que cortes em saúde devem ser cuidadosamente ponderados, 
principalmente em alturas de abrandamento das taxas de crescimento, pois melhorias na 
saúde pode fomentar o crescimento económico e a sua negligencia pode ter consequências 
negativas sobre as taxas de crescimento de uma economia. 
 
Palavras-chave: saúde, capital humano, crescimento económico, regressão por quantis 
Classificação JEL: C31, C33, I15, O15, O47 
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Abstract 
Health plays an unquestionable role in people’s welfare and the development of 
countries. As regards its contribution to economic growth, there are divergent views. Some 
views are based on estimates that only consider the impact of health on the average value of 
growth rates, ignoring the different effects of regressions on the different values of the 
dependent variable. In other words, ignoring that the influence of health can be 
heterogeneous depending on the evolution of the economy itself. The analysis developed in 
this work, for a maximum sample of 92 countries over the period 1980-2010, proves this 
heterogeneity. In fact, by applying an ad hoc growth regression where we followed the 
methodology of Canay (2011) for regression by quantiles (Koenker 2012a; Koenker 2012b), 
we found that variations in health have a positive impact on economic growth and that this 
impact is greater for countries with low growth rates. This results apply to either positive 
(life expectancy, consumption of calories per person per day) and negative (infant mortality 
rate, prevalence of undernourishment in populations) indicators. We thus conclude that cuts 
in health should be carefully balanced, particularly in times of growth slowdowns, since 
health increments foster growth and neglecting it endangers an economy’s growth. 
 
Keywords: health, human capital, economic growth, quantile regression 
JEL Classification: C31, C33, I15, O15, O47 
v 
 
 
Table of Contents 
 
1.	 Introduction ................................................................................................................ 1	
2.	 Health as a determinant of Economic Growth: Theory and Evidence ....................... 3	
2.1. Theoretical predictions on the nexus between health human capital and economic 
growth ................................................................................................................................. 4	
2.2. Empirics .................................................................................................................. 7	
3.	 Data overview .......................................................................................................... 10	
4.	 Empirical growth models and quantile regressions ................................................. 14	
5.	 Estimation Results ................................................................................................... 18	
6.	 Conclusion ............................................................................................................... 25	
References ....................................................................................................................... 26	
Appendix ......................................................................................................................... 30	
Annexes ........................................................................................................................... 31	
 
 
List of Tables 
Table 1. Descriptive statistics of the main variables ............................................................ 13	
Table 2. Estimates of the quantile panel model and fixed effects model for positive health 
indicators and health expenditure ................................................................................ 19	
Table 3. Estimates of the quantile panel model and fixed effects model for negative health 
indicators ...................................................................................................................... 20	
Table A. 1. Summary of selected empirical studies on the effect of health on economic 
growth 
Table B. 1. List of countries included in our broader sample’s data set 
Table B. 2. List of variables of our data set	
Table B. 3. Health variables’ correlation matrix (58 countries 1995-2010)	
vi 
 
  
Table C. 1. Quantile regression estimation results with Life expectancy as the main health 
related explanatory variable (1980-2010 for 92 countries)	
		
	
List of Figures 
Figure 1. Evolution of health coefficients estimates from quantile regression model ......... 22	
Figure B. 1. Scatterplot of average GDP per capita growth rates for period 1980-1995 and 
1995-2010 (92 countries) 
Figure B. 2. Density function of average per capita growth rate conditioned by the time 
period (92 countries for 1980-2010)	
Figure B. 3. Matrix of health variables interrelationships (scatter plots)	
	
  
List of Abbreviations 
ASR – Adult Survival Rates 
CVA – Cerebrovascular diseases 
FRED – Federal Reserve Bank of Saint Louis (2015) 
GDP – Gross Domestic Product 
LE – Life Expectancy 
OECD – Organisation for Economic Co-operation and Development 
PPP – Purchasing Power Parity 
PWT – Penn World Table 
USD – United States Dollar 
WDI – World Bank’s World Development Indicators (2014) database 
 
 
 
 
 
1 
1. Introduction  
Human capital is acknowledged as one of the most important sources of economic 
growth. As countries move towards knowledge-based economies, the existence of highly 
skilled human capital becomes increasingly important. It is thus not surprising that previous 
empirical research has focused on identifying the mechanisms of transmission from human 
capital accumulation to growth, and on assessing their magnitudes (see e.g. Benhabib & 
Spiegel 1994, 2005; Bloom et al. 2001; Howitt 2005; Hanushek & Woessmann 2011; 
Bleakley 2010). 
However, most of these studies focus on formal education as the main source of 
human capital, while the impact on growth of health human capital has been much less 
studied. Health helps increase labour productivity, the capacity to learn at school and to grow 
intellectually and physically. Simultaneously, the decrease of mortality and morbidity allows 
for an increase in the proportion of the working age population, therefore contributing to 
raise per capita income. They also mean higher longevity, which in turn creates a greater 
need for people to save for their retirement (Bloom & Canning 2012). It is thus not surprising 
that “several of the great ’takeoffs‘ in economic history […] were supported by important 
breakthroughs in public health, disease control, and improved nutritional intake […]” (Sachs 
2001; p.22). A look at some recent data at the World level (source: WDI – World 
Development Indicators) seems also to support this positive correlation. For instance, over 
the period 1970-2010 life expectancy at birth increased by 10 years – from 60 to 70 years of 
age for the average world citizen – and infant mortality rate decreased from 97.6 to 37.5 per 
1,000 births, while at the same time World GDP (Gross Domestic Product) per capita 
increased from 4240,72 to 7603,14 USD at 2005 PPPs (Purchasing Power Parity). The same 
conclusion applies to groups of countries defined according to income levels. 
At the empirical level, however, Lewis and Jack (2009), p.2 “[…] caution the reader 
against expecting to find consensus in the empirical literature on the links from health to 
growth or even from health policies to health”, highlighting the need to adopt econometric 
methodologies that deal with issues such as endogeneity and measurement error. As far as 
econometric methodologies for the study of the relationship between health human capital 
and economic growth are concerned, the empirical growth literature also usually assumes 
homogeneity among economic growth models by restricting the significance and magnitude 
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of the economic relations for the average country. However, it is unlikely that the impact of 
human capital on economic growth is the same, for instance, in the United States and in 
African countries. In addition, since many papers concentrate on specific countries, 
worldwide differences in the linkages are not adequately taken into account. Allowing for 
parameter heterogeneity in the study of the relationship between health human capital and 
economic growth in broad samples of countries can thus bring new insights. This is 
particularly true at a time when many countries are facing a period of crisis, with impressive 
growth slowdowns that demand a rigorous identification of the most effective sources of 
growth in periods of deceleration. For instance, in 2007 Angola recorded an output growth 
rate of 4.97% and the Euro Area a growth rate of 19.02%, but in the period following the 
financial crisis – 2008-2014 – the average growth rates declined to 1.74% and 1.75%, 
respectively (source: FRED). The identification of different impacts on growth of health 
human capital across the growth rate distribution can be especially important for countries 
facing fiscal sustainability issues, such as Portugal. In fact, investments in health are mainly 
publicly funded and a cut in public health expenditures, with the associated negative impact 
on health human capital, can be especially harmful for the output growth of under-
performers. 
The main aim of this paper is to empirically assess the importance of health human 
capital for economic growth in a broad sample of countries, explicitly taking into account 
the issue of parameter heterogeneity. For this purpose, we allow for differentiated effects of 
health human capital on the output growth rate, conditioned by the location of the dependent 
variable at different parts of its distribution. Additionally, we will analyse the sensitivity of 
our results to the use of different proxies for health human capital, trying in this way to 
overcome, to some extent, the measurement error problem. 
This paper applies a quantile regression approach to estimate output growth 
equations in order to account for parameter heterogeneity in the relationship between health 
human capital and growth in a sample of 60 countries over the period 1980-2010. Quantile 
regressions are used as a method to capture parameter heterogeneity across countries 
considering varied effects across different quantiles of the distribution of the dependent 
variable. The data used comes mainly from the Penn World Table 8.0, World Development 
Indicators, CANA and Barro and Lee data set. 
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The remainder of this paper is organized as follows: in section 2 we review the 
theoretical predictions and empirical evidence on the nexus between health human capital 
and economic growth. Section 3 contains descriptive statistics and analyses the main 
variables for our empirical study. In section 4 we present the empirical model and describe 
the methodological approach. In section 5 we present and discuss the results. Finally, section 
6 contains the main findings and some suggestions for future research. 
2. Health as a determinant of Economic Growth: Theory and Evidence 
Economic growth research is mainly concerned with identifying those economic 
structural characteristics that can explain differences in standards of living and income 
growth across countries. Since at least Adam Smith (18th century), the study of the effects of 
human beings on the behaviour of aggregate output has been a matter of debate (Savvides & 
Stengos 2009). Nonetheless, for a long time the focus was on physical capital as the main 
source of economic growth. The debate was reignited by the work on the economic role of 
human capital by Theodore Schultz (1960;1961) and Gary Becker (1964)1 during the second 
half of the twentieth century. As a result, human capital became widely recognized as an 
important source of economic growth.  
This link between human capital and economic growth has been explored and 
measured mainly considering formal education (Mincer 1981; Benhabib & Spiegel 1994; 
Miles 2004). During the 20th century, health improvements were impressive. It is thus not 
surprising that pioneer work concerned with understanding the role of nutrition (Fogel 1994) 
and longevity (Preston 1975) in explaining income variations across countries was 
developed. Investments in health showed an upward trend, with health expenditure per capita 
at the World level in 2011 international dollars (PPP) rising from 481 (1995) to 605.8 (2000), 
and World health expenditure in percentage of GDP increasing from 8.7 (1995) to 9.1 (2000) 
percent (source: WDI). As one might expect, these developments resulted in extending the 
concept of human capital to include, besides education, “the general state of health of the 
working population” (Savvides & Stengos 2009), which has become popular among 
                                                
1 These authors model education as an investment in human capital and highlight its importance to explain 
income growth at the individual/worker level. Schultz (1960), p. 572 considered that “a serious fault in the way 
capital is treated in economic analysis has been the omission of human capital”. See also Barro (1991) and 
Mankiw Romer and Weil (1992) that showed its importance at the macroeconomic level based on a theoretical 
growth model. 
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researchers, notwithstanding the divergences at the empirical level on how to measure this 
concept.  
It is important to notice, however, that the relationship between health and 
economic performance can be studied from two perspectives: the macroeconomic one, 
which considers the economic benefits of health for the aggregate economy, and the 
microeconomic one, that is concerned with the individual economic benefits of health human 
capital (see Lewis & Jack 2009). The first perspective is the one most closely related to 
growth theory and will thus be the focus of our analysis. 
2.1. Theoretical predictions on the nexus between health human capital and economic 
growth 
The benchmark for modelling the relationship between health human capital and 
economic growth is the neoclassical growth model, which has its genesis in the work 
developed by Solow (1956) and Swan (1956). Mankiw Romer and Weil (1992) emphasized 
the role of human capital in explaining income and growth differences across countries, set 
out in what became known as the Augmented Solow Model. 
Health, just like education, differs across individuals and consists of a stock that 
can depreciate or increase over time (Grossman 1972). Healthier workers are able to think 
better, are more focused, and allocate more energy and higher effort to task performance. It 
is therefore possible to say that health defines some of those workers’ qualitative 
characteristics that allow them to be more or less productive. Human capital in turn is defined 
as the characteristics that make a worker more productive as a result of a previous cost 
(Becker 1964; Filer et al. 1996); thus, better health results into higher human capital. 
Additionally, healthier workers are less likely to miss work due to sickness (Bloom & 
Canning 2000). The better is health for the same amount/number of labour/workers, the 
higher is their productivity and the output. Furthermore, if working-age population lives 
longer, more output can be produced, representing higher macroeconomic benefits from 
human capital health investment. 
As a consequence of the previous view, health is considered in neoclassical growth 
models as just another input into the production of final goods alongside physical and 
education human capital. In the light of the neoclassical growth theory, higher rates of 
accumulation of both human (health and education) and physical capital lead to permanently 
higher levels of income. However, since there are decreasing returns to capital, there will 
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only be transitory growth effects (see Weil 2005). In the long run, income per capita grows 
at the same growth rate as technological progress, assumed constant and exogenous, the 
main driver of economic growth. In any case, poorer countries are predicted to grow at a 
faster pace in the neighbourhood of the steady state growth equilibrium, after differences in 
structural characteristics across countries are controlled (Barro & Sala-i-Martin, 2004). 
Besides its role as an input into final goods production, health human capital can 
also play a role as an input into innovation and imitation activities. Endogenous growth 
theories that developed from the mid-1980s onward aimed at explaining how technological 
progress takes place (Jones & Vollrath 2013). AK-type growth models assume that human 
capital contributes to economic growth because workers with higher human capital levels 
increase not only their own productivity but also that of other individuals with whom they 
perform different tasks, thus overcoming the growth effects of the diminishing marginal 
returns hypothesis (Lucas 1988). 
Human capital is also viewed by endogenous growth theory as being of major 
importance for innovation and technology diffusion activities that result from intentional 
decision by economic agents (Romer 1990; Nelson & Phelps 1966; Barro & Sala-i-Martin 
2004). Countries differ in their production capacity and ability to improve it, with some 
countries relying on their ability to innovate and create new technologies (leader countries) 
and others on their ability to imitate those new technologies (followers). Human capital has 
the potential to influence both activities. According to this view, if health human capital 
increases, the knowledge inducing the production of new ideas/technologies will also rise, 
there will be more ideas available and thus more innovation will take place in the 
technological leader countries. In the follower countries, a better health status will increase 
their absorption capacity in terms of adapting and implementing the technologies developed 
by the leaders. 
Additionally, health human capital can produce an indirect growth impact through 
its influence over other growth determinants such as demography, education, physical 
capital, and income inequality and poverty (Bloom & Canning 2000; Howitt 2005; López-
Casasnovas et al. 2005). 
Mortality rates and life expectancy affect the demographic structure of a country. 
Higher life expectancy and lower mortality rates imply a greater number of individuals of 
working age that can thus contribute to higher output levels. Additionally, if they also imply 
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a greater proportion of the working age population it seems reasonable to expect that output 
per capita will also be higher. 
If the health status of the population increases, school absence due to sickness is 
expected to decrease. In the same way, health allows to enhance learning capacity, since 
individuals will be better prepared to learn both physically and intellectually. In particular, 
better nourished children will have better cognitive skills (Alderman et al. 2006). Moreover, 
if health increases occur in the form of decreasing mortality or increasing longevity, the 
higher will be the incentive to invest in education and acquire additional school 
qualifications. Since education is a source of human capital that is predicted to impact growth 
positively, healthier populations will also present higher educational attainment levels and 
perform better at school, which in turn leads to higher growth and income levels. Is it thus 
not surprising that several studies have considered the health-education nexus when studying 
the impact of the former on economic growth (Kremer & Miguel 2001). 
Moreover, increasing longevity influences savings decisions. If people expect to 
live longer, they will save more for their retirement. Higher savings rates will in principle 
lead to higher investment rates and thus more physical capital accumulation, which in turn 
fosters growth in the medium term (see Barro & Sala-i-Martin 2004). On the contrary, if 
people’s health is poorer and they have “a short time horizon because they expect to die 
young, they have less reason to save and the economy fails to grow.” (Lorentzen et al. 2008, 
p.82). 
Finally, promoting health can not only spur economic growth and development but 
also reduce poverty (Sachs 2001). In fact, health improvements have larger impacts on the 
standards of living of the less privileged people with poorer health (Deaton 2003). Poorer 
population which are better nourished see their education capabilities improve (Lorentzen et 
al. 2008) with positive consequences on their performance and economic growth. This is 
often the reason why improving the health status of the poorer is seen as a way to escape 
from poverty traps (Sala-i-Martin 2005). 
As a final remark, notice that health differentiates itself from other economic 
growth sources due to its role at the social level that makes it a very sensitive area of 
intervention for both policy makers and individuals. We acknowledge that investments in 
health are fundamental at the social and humanitarian level, besides their role on economic 
performance. 
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2.2. Empirics 
At the empirical level researchers have yet to reach a consensus on the impact of 
health status and accumulation on growth. Most previous empirical works find a positive 
relationship between health and economic growth, supporting the pioneer work of Preston 
(1975)2. Likewise, there is evidence pointing to health as an important growth determinant 
regardless of the period under analysis, type and number of countries included in the sample, 
health proxies used, and model specification (control variables included; ways of introducing 
health variables). However, negative and statistically significant impacts of health on output 
growth are also found (see Lewis & Jack 2009). There is also the possibility that the health 
proxy considered accounts for mismeasured/not included factors, as first suggested by Barro 
& Sala-i-Martin (1995). This has led economists to search for patterns across specific regions 
and among countries within the same group of income level (Eggoh et al. 2015; Poças & 
Soukiazis 2012; Aghion et al. 2011; Bhargava et al. 2001). Nevertheless, estimation results 
seem sensitive to the health proxies used and the health interactions considered. The 
following subsections provide a more detailed discussion on the matter. Table A.1. in annex 
A provides a summary of the empirical studies reviewed in this section. 
As far as panel data studies with wide samples of countries are concerned, Bloom 
et al. (2004) review some previous studies that use life expectancy to proxy health and 
conclude from this literature review that the majority find a positive effect running from the 
initial level of health to output growth. They also estimate an economic growth regression, 
with life expectancy (initial level) as the main explanatory variable, over the period 1960-
1990 and with a sample of 104 countries. They start with an aggregate production function 
that takes into account differences in productivity among countries. The results found point 
to statistically significant and positive coefficients for life expectancy, suggesting that health 
affects economic growth through its direct impact on labour productivity. 
Also using life expectancy to measure health human capital accumulation, 
Acemoglu & Johnson (2007) arrive at a negative coefficient for a sample of 47 countries 
over the period 1940-1980 implying that faster health accumulation is not beneficial for 
economic growth. The authors explain these results on the basis of a Malthusian effect (the 
idea that population growth is expected to exceed resources growth) since for the period 
                                                
2 Preston’s (1975) work finds a strong positive correlation between life expectancy and income. 
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under analysis life expectancy grew at the same rate as the population. In line with this work, 
Aghion et al. (2011) mainly aim at proving that, even when using different instruments for 
health, negative versus positive coefficients are due to a missing effect: health in some 
countries grows faster because they have lower initial levels of health (health convergence). 
They estimate a cross country regression for 96 countries where they find a positive impact 
going from health to growth although health growth/accumulation reveals to be less robust3 
(beyond a certain point health growth becomes statistically insignificant). They also 
instrument life expectancy with the same instrument variables as in Lorentzen et al. (2008), 
whose focus is on the relationship between life expectancy and adult survival rates4, but the 
results remained almost the same. Additionally, for the same time span Lorentzen et al. 
(2008) explore other channels of interest through which health might influence growth; they 
conclude that, when investing in physical capital and influencing fertility rates, health can 
affect growth in a quantitatively more important way than through human capital 
investments. Aghion et al. (2011) follow their lead and also extend their work to ascertain 
these mechanisms, although in their work both the initial level and the growth rate of health 
influence the level of fertility whereas health impacts investment in human and physical 
capital. 
Cooray (2013) and Soukiazis & Cravo (2007) try to disentangle in a different way 
the relationship between health and economic growth by grouping the sample according to 
countries’ income levels. They also use health in the form of life expectancy, but Cooray 
(2013) uses a sample of 210 countries and Soukiazis & Cravo (2007) 77 countries (for the 
periods 1980-2000 and 1990-2008, respectively). Despite using the same health proxy, 
Cooray (2013) finds correlation between health and other variables such as health 
expenditure and education while Soukiazis & Cravo (2007) do not. Increasing health, 
according to the results in Soukiazis & Cravo (2007), is growth enhancing for low income 
countries whereas it has no statistically significant impact in high income countries. When 
Cooray (2013) uses adult survival rates as a proxy for health, the results found point to a 
positive growth influence in upper middle and high income countries while the influence is 
negative in low and low middle income countries. 
                                                
3 Results only of the Bayesian approach also applied. 
4 Lorentzen et al. (2008) use an instrumental variable approach, more specifically they regress economic 
growth with life expectancy and use adult survival rates as instrumental variables. 
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The study by Bhargava et al. (2001) measures health as adult survival rates 
considering a sample of 92 countries and obtains results similar to those of Soukiazis & 
Cravo (2007). Their results, notwithstanding, indicate that the impact of health on growth is 
significant until it reaches a certain threshold, above which it becomes insignificant, 
providing a possible and reasonable explanation for the differences in the estimated results 
of other studies. 
Similarly to some previous studies, Cooray (2013) also explores the interrelations 
(with interaction terms) between health and other variables that might influence economic 
growth. The author finds statistically significant and positive effects of health on education 
human capital (in line with results of the previous studies of their review) and health 
expenditure. 
In addition, Wang (2011) investigates the impact of health expenditures on growth 
by estimating a growth regression for 31 countries over the period 1986-2007. The author 
examines the health-growth link from a different perspective to provide a complete picture 
of the influence of health on economic growth in what concerns the existence of non-
linearities. In particular, he applies a quantile regression approach to identify different health 
expenditures growth impacts at different parts of the output growth rates distribution The 
results obtained indicate that there is a positive influence among middle and high performers 
in terms of output growth, while for low performers the influence is negative. 
By contrast, some researchers narrow the sample to specific countries within a 
geographical region or an institutional group, trying in this way to have a deeper 
understanding of the health contribution to economic growth (e.g. Eggoh et al. (2015) for 
African countries and Poças & Soukiazis (2012) for OECD countries). They both try for the 
use of several variables to quantify health (see table A.1.). Poças & Soukiazis (2012) find 
evidence that health boosts growth in OECD countries, especially when measuring the 
dimension of health care quality and the mortality rates of specific diseases. On the other 
side, Eggoh et al. (2015) inference that increasing health expenditure may have a negative 
influence on growth, even though the level of health expenditure for the countries is low, 
when education expenditures are below a certain threshold. 
A matter of great importance concerns the ability to statistically summarize all the 
information of a particular relation between variables using usual estimation techniques. In 
general, when addressing health impact on economic growth, linear regression estimates the 
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average effect of health on output growth rates. In this way it is possible to assess if health 
is important for economic growth. On the other hand, it cannot provide information on 
whether health influence on economic growth differs for under-performers more than for 
average performers. Soukiazis & Cravo (2007), Bhargava et al. (2001) and Cooray (2013) 
try to go beyond the usual thinking and figure that by dividing their sample into three 
different groups according to their income levels (low, middle and high income countries) 
they could look for differences in the effects covariates could have on the dependent variable. 
The main goal of this work is to give a more comprehensive picture of the effects of health 
on growth on the basis of differentiated impacts according to the distribution of output 
growth rates. This is achieved by using an appropriate estimation methodology – quantile 
regression approach – that makes it possible to model the relation between a set of variables 
and a quantile of the dependent variable and thereby account for heterogeneous effects of 
the covariates. The effect of health on output growth rate can then be compared with its 
effect on the median or other quantiles of the output growth rate. Indeed, the coefficients 
obtained through quantile regression estimation are comparable to conventional linear ones. 
Despite the theoretical arguments in favour of a positive and important influence of 
health on economic growth, in the empirical literature there are still some gaps to fill in order 
to get a better understanding of the role of health on long run economic growth rates. The 
main aim of this work is to contribute to shed additional light on the understanding of the 
health-growth nexus by applying quantile regressions in order to seek for new potential 
implications from the results obtained. Not only do we want to allow for a more complete 
view of health influence over economic growth rates using this methodology, we also want, 
by considering different health proxies, to contribute to develop new insights and some 
consensus as well as to stimulate future research on the topic. The most commonly used 
proxy for the health status of the population is life expectancy. In this study, although data 
availability did not allow us to consider as many dimensions of health as we had initially 
planned, we are still able to capture the two dimensions: health status and health investment. 
3. Data overview 
Our broader sample includes balanced panel data5 for 92 countries (see in annex B 
table B.1) from 1980 to 2010. The data needed for the estimation of our growth regressions 
                                                
5  In order to have a balanced panel we applied some valid data manipulation procedures detailed in 
Appendix I. 
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were computed with information obtained mainly from the Penn World Table (PWT) 
(Feenstra et al. 2015), version 8.0, and the World Development Indicators (WDI). We chose 
these two databases due to the need to ensure international comparability of the data for a 
large sample of countries, including data for health human capital and for standard growth 
determinants identified in previous empirical and theoretical growth studies. 
Using data originally from the PWT 8.0 we computed data for real GDP per capita 
at constant PPP by dividing output at constant international PPP at 2005 prices by total 
population. From the WDI we extracted several health proxies based on the following 
criteria: firstly, the availability of data for long periods of time and relative to a high number 
of countries; and secondly, our interest in capturing different growth effects through several 
perspectives of health. 
Although health status and changes of a population are difficult to measure, the 
classical proceeding for health’s evaluation is based on 5 D’s: death, disease, disability, 
discomfort, and dissatisfaction (Lohr 1988). These provide negative outcome indicators and 
therefore the doubt remains whether it is more accurate and conceptually correct to measure 
the lack of health (negative indicators) rather than its existence (positive indicators). The 
latter refers to wellness and quality of life, which involves a lot of subjectivity in its 
measurement. Thus, besides the criteria for selecting health variables previously described, 
we also considered both positive and negative health indicators. We are thus able to account 
for these two dimensions of health status. The positive health indicators used are life 
expectancy, female and male survival rates to the age of 65, and consumption of kilocalories 
per day per person. The negative health indicators are female and male adult mortality rates, 
infant mortality rate and the prevalence of undernourishment. Finally, we also proxy for 
health investments using health expenditure per capita. For a summary of the variables 
gathered in our database see Table B.2. in annex B. 
In order to assemble our data set, we started by considering all the countries for 
which there was information in the two main databases, the PWT and the WDI. We next 
excluded some observations based on the following criteria: first, we excluded from the 
sample current members of the Organization of the Petroleum Exporting Countries (OPEC) 
and small countries6. Standard growth determinants are probably not able to explain the 
                                                
6 Countries with population lower than one million according to WDI 2014 data. 
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reality of those countries with their respective growth performances explained by very 
specific factors related to oil production in the first case and scale in the second. Second, we 
also dropped from the data set countries with insufficient information regarding the key 
variables for this study and whose real output observations started only after the year 1985. 
Finally, for each health indicator we adjusted the period and number of countries according 
to data availability and used index conciliation as well as other manipulation techniques7 to 
fill the gaps of all the variables included in our data set. 
As we can see in figure B.1 in annex, that contains an overview of the output per 
capita growth density function conditioned by the time period, the estimated density function 
of average growth rates over time shows a peak. This indicates a concentration of the 
probability mass, suggesting that the observed growth rates are likely to be close to the output 
growth rate values associated with the peak. Table 1 presents a brief summary of the main 
variables’ data distribution based on the respective descriptive statistics. According to the 
information presented in Table 1, we confirm a leptokurtic shape (kurtosis > 3) related to the 
unconditional distribution of output growth rates, indicating also a high concentration of 
values and a low standard deviation. Nevertheless, it is important to highlight figure B.2 in 
annex that presents a scatter plot relating the countries’ average growth rates for two sub-
periods 1980-1995 and 1995-2010. Although most of the dots are in the first quadrant, 
explaining the huge concentration of observations previously mentioned, there are 
considerable observations in the other three quadrants. This implies that some of the 
countries in our sample have registered very different figures for the respective average 
growth rates over that time span. This observation supports the importance to further 
investigate whether the explanatory variables we considered in our growth regressions have 
different growth impacts across different parts of the distribution of the output growth rate, 
our dependent variable. 
Regarding health indicators, health expenditures, adult mortality rates (female and 
male) and the consumption of calories also present a high concentration of values with a 
skew to the left (higher in health expenditure) noting that the probabilistic mass 
concentration is on the left of the mean; this leads us to think that the main observations do 
not reflect the mean observations, as we pretend to ascertain in this work. With regard to the 
                                                
7 Our data manipulation involves autoregressive processes fitted to the data (for more details see appendix 
I). 
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other health indicators (table 1), they seem to present a flatter distribution (level of kurtosis 
under 3), indicating that there are differences in the values of those indicators across 
countries or within countries over time, reflected in longer tails, and therefore less 
concentration of the data near specific values. In what concerns the distribution of adult 
survival rates, it appears to be similar for both genders. Regarding adult mortality rates, the 
respective distribution seems to have a higher concentration of values of female rates on the 
left side as compared to the distribution of male rates. 
Since one of the objectives of this work is to assess the sensitivity of health growth 
influence according to the different health proxies used, it is relevant to understand how they 
relate to each other. Figure B.3. in annex B presents scatterplots of the relationships between 
health indicators of our data sets, and table B.3. in annex their correlation matrix. The 
negative indicators (such as mortality rates and population undernourished) are negatively 
                                                
8 Relates to Pearson’s measure of kurtosis. The levels of kurtosis under 3 correspond to leptokurtic shape 
distribution, above 3 correspond to leptokurtic shape distributions and equal 3 present a mesokurtic distribution 
just like the normal distribution. 
 
Variable Obs. Mean Stand. Deviation Median 
1st 
quantile 
(0.25) 
3rd 
quantile 
(0.75) 
Skewness Kurtosis8 
∆"#$ 552 0.0166 0.0392 0.0175 -0.0043 0.0369 0.1015 10.5891 "%"& 552 64.77 11.1228 67.94 56.08 74.11 -0.5758 2.3986 '().+ 552 0.6095 0.1618 0.6333 0.4864 0.7448 -0.4326 2.2845 '(). , 552 0.6969 0.1785 0.7478 0.5577 0.8520 -0.6119 2.2824 %+) 534 0.0494 0.0419 0.0371 0.0114 0.0798 0.8106 2.7536 '+).+ 540 0.2595 0.1240 0.2376 0.1629 0.3237 1.0095 3.8992 '+). , 540 0.1926 0.1302 0.1491 0.0886 0.2689 1.2343 4.3889 %"-. 270 820.93 1062.645 343.13 90.32 1248.04 1.9133 7.3132 /#0&) 252 0.2111 0.1331 0.1945 0.1003 0.3050 0.5538 2.6678 %"12'" 252 154.400 105.1652 142.344 70.125 229.000 0.7449 3.3587 
Source: authors’ edit. 
Notes: ∆345	- real GDP per capital average growth rate; 3738	- life expectancy; 9:;.< - initial level of adult 
male survival rate; 9:;. =	- initial level of adult female survival rate; 	7<; - initial level of infant moratality 
rate; 	9<;. =	- initial level of adult female survival rate; 	9<;.< - initial level of adult male survival rate; 	73>ℎ 
- initial level of public health expenditure per capita; 	@4A8;	– initial level of prevalence of undernourishment; 	73BC93 – initial level of consumption of calories per day per person. ∆345, 3738, 9:;.<, 9:;. =, 7<;, 9<;.<, 9<;. = relate to 1980-2010. 37>ℎ realte to 1995-2010 and @4A8; and 7BC93 relate to 1990-2010. 
Table 1. Descriptive statistics of the main variables 
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correlated to the positive ones (life expectancy, survival rates, consumption of calories), as 
expected. Although the correlation between health expenditure and the other health 
indicators does not seem to be linear, as opposite to what we see for the other correlations, 
it appears to present a positive sign relative to the positive indicators and a negative sign 
when correlated with negative indicators, as expected. In terms of the possible influence of 
health on economic growth, we expect that negative health indicators have a negative effect 
on economic growth, while positive health indicators should influence growth positively. 
4. Empirical growth models and quantile regressions 
In order to assess the importance of health and its different proxies for long run 
growth we estimate what is known in the literature as an ad hoc growth regression (Barro & 
Sala-i-Martin 2004) since it is not directly derived from a particular growth model but 
incorporates growth determinants highlighted by both the exogenous and the endogenous 
growth literature. We consider each health proxy in turns (to avoid collinearity), alongside a 
set of control variables factors identified as important growth determinants in the empirical 
and theoretical economic growth literature (see annex A). 
Our baseline growth regression is given by equation (1): 
∆D	EFGH 	= 	JK + JMℎNOPM + J′[S…U]WNO + XNO     (1) 
where ∆DY	EFGH , the dependent variable, is the real GDP per capita annual average 
growth rate for each 5-year period; ℎNOPM, the main explanatory variable, is the proxy for 
health given by the initial level of the variable for each 5-year period; the vector X contains 
the control variables identified according to previous theoretical and empirical literature - 8A@CNO is educational human capital proxied by Barro and Lee (2010) average years of total 
schooling; 35NOPM is the log of initial real GDP per capita (for each 5-year period) that controls 
for the existence of convergence among the countries in our sample; >=C=NO is the share of 
fixed capital formation in GDP; 4NO is the average population growth for the 5-year interval; >NO is average government consumption share in output for 5-year period and 3Z[84NO is the 
logarithm of trade share in output (see annex B table B.2). JK is a constant term and εNO the 
error term with the usual properties. 
We assume that better health status plays a key role in fostering workers’ 
productivity. Thereby, real income per capita rates are thought to change in line with life 
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expectancy, survival to age of 65, kilocalories per day and health expenditure per capita; and 
to vary inversely with adult mortality rates and infant mortality rates and the prevalence of 
undernourishment. Increasing production capacity by investment in physical capital or in 
education represents the possibility of increasing the amount of output, and therefore these 
investments also play an important role in explaining differences in growth rates across 
countries. But not only capital influences countries’ growth rates, the initial level (supported 
by neoclassical approach) of output of a country will affect their performance as well. Lower 
growth rates are associated with countries with levels of output close to their equilibrium, 
whilst higher growth rates are assumed for countries far from their potential output. 
Population growth rates are also considered in the neoclassical framework and are used as a 
proxy to increments on the labour force. According to the classical hypothesis, in 
equilibrium, countries grow at a constant rate that depends on population growth. Besides 
this, a country’s GDP per capita rises whenever countries expand their market to foreign 
countries and allow for more products to be traded with the rest of the world, and therefore 
the outlook for raising GDP per capita increases in the long run. Finally, Barro (1990) 
considers the share of government expenditures as a powerful determinant of growth rates. 
He argues that increasing the share of non-productive government expenditures, where the 
inexistence of resulting impacts on productivity is implicit, can lower growth by lowering 
saving rates.  
Taking the standard deviation (see table 1) of life expectancy, it is expected that we 
come across huge differences among some countries of the sample, namely regarding public 
health expenditure per capita and calories consumption per day per person. For example, life 
expectancy at birth in Cambodia in the beginning of the period 1980-1985 was around 28 
years whereas, in the same period, it was near 76 years in Sweden. Perhaps if both countries 
increase life expectancy in the same amount, the gains in terms of output growth arising from 
that increase are lower for Sweden and the effort made towards it is higher. We thus assume 
it has decreasing marginal returns, the same being applied to health expenditure and calories 
consumed per day per person. For this reason, we model differently these three variables: 1 ℎNOPM. However, this reasoning does not apply to mortality rates because it is assumed that 
higher mortality has a detrimental impact on output growth since it means poorer health. 
Additionally, we opt for long run specification as a 5-year interval sample and thereby try to 
empirically overcome the endogeneity between output growth and health. We also benefit 
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from using panel data, that permits to control health variables’ measurement errors (Schultz, 
1994). 
We have estimated equation (1) using quantile regression aiming at identifying 
health effects beyond those allowed by conventional procedures. This method, first proposed 
by Koenker & Bassett (1978), estimates models for conditional quantile functions, ^_(Y/X). 
This means that the influence of a set of variables X on Y is estimated for univariate quantiles e ∈ (0,1) of the distribution of Y rather than focusing on the expectation of the response 
variable as do least squares estimation. The mean effects reflect only a specific part of the 
distribution (central), and similarly univariate quantiles of the empirical distribution also 
correspond to a particular location of the distribution with value y such that i j ≤ 5 = e. 
So, thinking of quantiles as a central part of a particular location of the distribution (like 
median and mean are) makes it possible to solve the minimization problem in the same way 
as the conditional mean9. 
In summary, the estimators of quantile regression minimize a weighted absolute 
sum of deviations given by: J_ = argmin 1 − e 	 5NO − W′NOJ_N∈ N:	EFGtuvFGw + 	e	 5NO − W′NOJ_N∈ N:	EFGxuvFGw           (2)           
By applying the quantile regression procedure, it is possible to generate estimates 
of the influence of the covariates on the dependent variable for each quantile e of the 
distribution of the response variable. Due to the complexity in applying this procedure it is 
computed with the linear programming procedure available in R studio (Koenker 2012b).  
The quantile regression approach presents several advantages when compared to 
conventional estimation methods such as OLS. The most obvious one refers to the fact that 
it provides summary statistics on both central and tail distribution of the response variable 
allowing for a more complete investigation of the influence of specific covariates10. Quantile 
regression is also a more robust estimation procedure when the errors are not independently 
and identically distributed. It is also more robust to outliers since the estimators minimize 
asymmetrically absolute deviations. Furthermore, we can easily compare regression 
coefficients of specific quantiles to least squares estimates. The interpretation is very similar: 
                                                
9 For the median (e = 0.5) the problem is solved minimizing the absolute sum of deviations.  
10 The quantile regression produces similar results to conditional mean estimation when the model fits the 
classical linear hypothesis. 
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a one-unit increase in the predictor variable associated to the estimated coefficient produces 
a change in the dependent variable expressed by the coefficient obtained for the specific 
quantile of the response variable. 
Furthermore, longitudinal data enables us to control for unobserved fixed effects. 
To address the overparametrization resulting from the parameter heterogeneity (Koenker 
2004) we eliminate the fixed effects by the method proposed by Canay (2011). This consists 
of a two-step estimator that is consistent and asymptotically normal as both the number of 
individuals and the time span grow. Assuming that fixed effects affect all quantiles in the 
same way, the effect on the conditional mean will also be the same. Therefore, in a first step, 
we estimate the conditional mean within the model and then purge this model from the 
individual effects. In a second step, it is thus possible to run a simple quantile regression 
after subtracting the individual effects from the dependent variable. 
Most studies previously reviewed either in this work and in Bloom et al. (2004) 
seek to identify health status effects on economic performance but fail to account for the 
entire conditional distribution of the output growth rate. Wang (2011) and Miles (2004) are 
examples of studies that investigate heterogeneous effects of different growth determinants. 
Miles (2004) focus on educational human capital neglecting the role of health. This author 
considers a sample of 77 countries for the period 1970-1998 and applies a pooled quantile 
regression approach11. This study finds different marginal effects of human capital between 
slow growers and fast growers. Wang (2011) using the same quantile approach finds 
differences in the effect of health care expenditures across the distribution of the output 
growth rate. More precisely, for higher growers he finds health expenditure growth 
enhancing whilst it has the opposite influence on slow growers. 
In our analysis, we address our main purpose estimating firstly a within panel model 
for a better discussion and comparison of the estimation results with those obtained when 
applying the fixed effects quantile regression proposed by Canay (2011) (for 0.05, 0.25, 0.5, 
0.75 and 0.95 quantiles). In the next section we present and discuss the results obtained. 
                                                
11 Thus different from our approach. 
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5. Estimation Results 
In this section we present the results of estimating our baseline growth regression 
with the different health proxies for our sample of a maximum of 92 countries over the period 
1980-2010. Before estimating our different growth regressions, we applied unit root tests12 
to all variables and residuals of the regressions and all proved to be stationary13. This way, 
we eliminate the possibility of spurious estimations.  To estimate the least squares model we 
thought relevant to apply the Hausman (1978) test14 in order to confirm fixed effects 
consistency that otherwise would jeopardize the panel methodology from Canay (2011). The 
results from these preliminary tests allowed us to proceed to the estimation of our growth 
regressions with quantile techniques. 
As far as the results from the quantile regression estimations are concerned, we 
present them in two different ways in order to facilitate the interpretation of our findings. On 
the one hand we plot the evolution of the marginal effects of the different health proxies 
across quantiles, at a 90% confidence intervals, together with the marginal effect of the least 
squares estimation also at 90% confidence intervals. Additionally, for each variable we 
present the results of the test of coefficient homogeneity15 across quantiles along the output 
growth rate conditional distribution. The null hypothesis indicates equality of slopes across 
quantiles, so if the test rejects the null hypothesis we are in the presence of significant 
differences in slope coefficients for the explanatory variables. Furthermore, to allow for a 
clearer interpretation of the graphical analysis, table 2 provides an overview of the health 
proxies’ estimated coefficients for positive indicators and health expenditure. For the 
estimation, we considered five e’s (e = 0.05,0.25,0.5,0.75,0.95) because we considered that 
in his way we can better understand the dynamics of the changes in coefficients among the 
conditioned distribution. 
                                                
12 For this purpose we apply the Levin-Lin-Chu (2002) test in GRETL (see appendix II for details). 
13 Aside from prevalence of undernourishment, calories intake and health expenditure that we were not 
able to perform the test. 
14 This test evaluates the consistency between the fixed effects estimator and the random effects estimator. 
We use the method swar, amemiya, walhus and kinla to estimate the random panel model and the output 
obtained was the same (rejecting the null hypothesis of fixed effects inefficiency). 
15 The test is the Wald test for marginal effects equality (Koenker & Bassett 1982). 
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 Figure 1 plots the estimated coefficients for the different health proxies across 
output growth quantiles. As we can see in figure 1, part (a), the inverse of the life expectancy 
logarithm (ilie) shows a negative coefficient, as expected, that decreases from low (slow 
growers) to high (fast growers) deciles. These findings suggest that an increase in life 
expectancy, that corresponds to a decrease in ilie has a positive impact on growth (ilie and 
growth rates vary inversely so life expectancy varies positively with growth rates). The 
estimation coefficients (table 2) are all statistically significant at 0,001% with the exception 
of the coefficient for the 0.95 quantile that presents no significance and 0.75 quantile 
significant at only 0.01%. It is important to bear in mind that adding to statistically 
significance and apparent different slopes for the estimated quantiles, also the p-value of 
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e = 0.05 -1.7878*** -0.0432 0.0087 0.1458* -0.8442*** 
(0.3737) (0.0315) (0.0700) (0.0633) (0.1139) e = 0.25 -1.9006*** -0.0628* -0.0176 0.1675*** -0.7918*** 
(0.3693) (0.0277) (0.0385) (0.0362) (0.0775) e = 0.50 -1.2211*** -0.05219. -0.0410 0.1373** -0.7583*** 
(0.3199) (0.0281) (0.0417) (0.0457) (0.0568) e = 0.75 -0.9630** -0.0688* -0.0924* 0.1717*** -0.8599*** 
(0.3047) (0.0343) (0.0392) (0.0411) (0.0662) e = 0.95 -0.8711 -0.0383 0.0158 0.0646 -0.8858*** 
(0.7011) (0.0417) (0.0817) (0.0926) (0.1465) 
Equality slope test 
2.9263 1.5782 0.9327 1.6671 1.2765 
(0.0198)* (0.1773) (0.4440) (0.1548) (0.2772) 
No. countries 92 63 92 92 90 
Time period 1980-2010 1990-2010 1980-2010 1980-2010 1995-2010 
Source: Authors’ calculations in R software and edit. 
Notes: 3738 - life expectancy; 9:;.< - initial level of adult male survival rate; 9:;. = - initial level of adult 
female survival rate; 73>ℎ - initial level of public health expenditure per capita; 	73BC93 – initial level of 
consumption of calories per day per person. Standard errors in parenthesis. For equality slope test is presented 
the test’s statistic ant in parenthesis the p-value. ***, **, * and ‘.’ denote the statistical significance at the 
0.1%, 1%, 5% and 10% levels, respectively. 
 Table 2. Estimates of the quantile panel model and fixed effects model for positive 
health indicators and health expenditure 
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equality slope coefficient test indicate that in this case it is rejected the null hypothesis of 
equal slopes for life expectancy in the growth regression. 
Table 3. Estimates of the quantile panel model and fixed effects model for negative 
health indicators 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Authors’ calculations in R software and edit. 
Notes: 7<r - initial level of infant moratality rate;	9<;. = - initial level of adult female survival rate; 	9<;.< 
- initial level of adult male survival rate; @4A8; - initial level of prevalence of undernourishment. Standard 
errors in parenthesis. For equality slope test is presented the test’s statistic ant in parenthesis the p-value. ***, 
**, * and ‘.’ denote the statistical significance at the 0.1%, 1%, 5% and 10% levels, respectively. 
In addition to life expectancy, kilocalories per day per person (ilkcal) is also a 
positive indicator and since it is introduced in the regression as the inverse it is expected that 
the estimated coefficient has a negative sign (just like life expectancy). According to the 
results presented in figure 1 (b) and table 2, the estimated coefficients for this variable 
confirm the expected negative sign. Figure 1 part (b) suggests that the influence of 
consumption of calories in the quantiles of growth rates’ distribution is quite similar to the 
results obtained when the regression is estimated by least squares up to the around 0.8 
quantile, when the magnitude becomes lower. However, the lowest (0.05) and highest (0.95) 
quantiles estimated coefficients are not statistically significant and the coefficients for the 
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No. countries 89 90 90 63 
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other quantiles are very similar which is indeed confirmed by the output of equality slope 
test. 
The adult survival rates as well as the adult mortality rates were disaggregated by 
gender (amr.m, amr.f and asr.m, asr.f, m for males and f for females). The results on both 
indicators differ from the previous positive indicators mostly for male adult rates. Apart from 
no parameter heterogeneity found by the test on both positive and negative indicators 
whether male or female, the statistical significance for males is only evident in quantile 0.75. 
By contrast, the estimators for female variables seem more significant and at more locations 
of the growth rates distribution. Still regarding female rates, the quantile 0.95 has the lower 
coefficient but is not significant, like estimators from other health proxies. Also, apparently 
there is no trend for health coefficients along quantiles, as previously, which we can confirm 
by looking at figure 1 (d) and (f). For instance, as far as female survival rate is concerned, 
the correlation is positive for all quantiles but the magnitude of the impact does not show a 
monotonic behaviour: it increases from the 0.05 to the 0.5 quantiles, it then decreases when 
we move to the 0.5 quantile to increase again for quantile 0.75 when it reaches its highest 
value (table 2). This pattern also applies to the estimated coefficients for the female mortality 
rate (table 3), in absolute values, since the estimated coefficients are always negative as 
expected. The main difference remains in the significance for levels of growth rates in 
quantile 0.05 where female adult mortality rates are not significant. 
The trend in the behaviour across quantiles of the estimated coefficient for the infant 
mortality rate (imr) is similar to that obtained for life expectancy (see figure 1 (a) and (g)). 
The statistical significance is identical too: no significance is found for the 0.95 quantile, 
and the 0.75 quantile coefficient is now even more significant (from 0.01% to 0.001%). The 
bigger difference in the results produced by infant mortality rate as proxy shows up in the 
test of parameter heterogeneity for each variable of the model, where the null hypothesis of 
parameter homogeneity is only rejected at 10% (against 5% for life expectancy slope test). 
So, at 10% the infant mortality parameters are not homogeneous. 
As for the share of undernourishment in population (under), the estimated 
coefficients are negative as expected and some are also statistically significant. And once 
again it is clear from plot analysis (figure 1 (h)) that running from low quantiles to higher 
quantiles of growth rates distribution the coefficient magnitude tends to increase. Not only 
is this tendency observable as the test for equality of coefficients emphasize it rejecting the 
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hypothesis for coefficients’ equality at 0.01%. Though for 0.05 and 0.95 quantiles 
prevalence of undernourishment is not statistically significant. 
(a) (b) 
(c) (d) 
(e) 
(g) (h) 
(i) 
(f) 
Figure 1. Evolution of health coefficients estimates from quantile regression 
model 
Source: R software output. 
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Also confirming theoretical predictions, the estimated coefficients on the inverse of 
the initial level of public health expenditure per capita (ilgh) are negative and statistically 
significant across all quantiles considered (see table 2). Once more, the slope related to health 
expenditure is negative because, as previously explained, the equation is estimated with its 
inverse (ilgh). However, regarding the magnitude of the estimated coefficients, although the 
results for the slope equality test do not reject the null hypothesis of equal slopes, they seem 
to be slightly higher for median and around 0.8 quantile of the growth rate distribution. From 
the inspection of the plot (figure 1 part (i)) of the estimated coefficients for the variable 
related to health expenditure (ilgh) we see that the black line, that represents the quantiles’ 
coefficients, does not cross the red dashed line that represents the least squares confidence 
intervals, thus confirming in part that coefficients do not greatly differ from the least squares 
estimation. Our results suggest that when countries face public finances sustainability crisis 
they should cut public expenditure carefully in order not to jeopardize long term output 
growth, specially for countries like USA where health expenditures are mainly publicly 
funded. This is in line with the findings of Wang (2011) for the period 1986-2007 who found 
a positive effect, however with opposite signs for the coefficients of fast growers (positive) 
and slow growers (negative). 
Regarding the control variables, they present similar results in every estimated 
regression. In table C.1. in annex C we present the estimation coefficients of the quantile 
regression as well the within least squares model considering life expectancy to proxy health. 
The equality slope test revealed parameter heterogeneity in education (educ), confirmed 
already by previous studies (Miles 2004). The coefficients are statistically significant and 
the sign is positive as expected. The variable controlling for convergence (ly) also presents 
the expected sign (negative) and is statistically significant across quantiles. Also statistically 
significant and with the expected sign in all quantiles is the variable which measures the 
countries’ openness. Population (n) in spite of being statistically significant at 0.01% in 
within model estimation, is only significant in quantile regression estimation at the 0.05 and 
0.25 quantiles (at 10%). Government consumption (g) on the other hand is not statistically 
significant in any quantile. For gross fixed capital formation (gfcf), the sign is negative which 
could be explained by non productive investments in that period of time that hence could 
have led to a crowding-out effect having negative consequences on the economy’s 
performance. 
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In overall terms, it is observed for the period under analysis that enhancing 
countries’ output per capita long run growth rates could be done by increasing the level of 
their population’s health. These findings are evident through every health proxy used for 
regressing growth either with positive or negative indicators. The coefficients for the 0.95 
quantile are not statistically significant (except for health public expenditure). However, they 
differ in certain aspects. An observable effect for this period, relates to female health that 
particularly shows to have influence on economic performance. This could be related to the 
increasing participation share of female in the labour market in the last decade leading 
therefore to the influence of health in this period to be mirrored into women’s health changes 
influence. Or even it could be indicating that the economic gains from female’s health are 
higher than from males’. Related to possible females’ health externalities on others, namely 
infants that hence contribute more to foster economic growth16. Nevertheless, the magnitude 
trend through levels of growth performance is unclear, thus requiring a more exhaustive 
investigation in order to make inferences about it. 
The most outstanding issue particularly concern life expectancy, infant mortality 
rates and undernourishment results, which unfold a rather interesting correlation between 
the level of quantiles of growth rates and the initial level of health. To date, studies’ estimates 
on the subject have been only considering the impact of health on the average value of 
growth rates, ignoring the different effects of regressions on the different values of the 
dependent variable. In other words, ignoring that the influence of health can be 
heterogeneous depending on the evolution of the economy itself. Our analysis proves this 
heterogeneity. The output from equality slope’s test and the coefficient values show different 
positive influence of better health according to growth rate of real GDP per capita 
distribution location. Changes in population’s health have greater impact on countries whose 
growth rates are low (0.05 and 0.25 quantiles), comparing to those performing above the 
median growth rate (0.75). Therefore, slow growers benefit more from an increase in health 
than faster growers, once more stressing the importance to carefully take into consideration 
health investments in periods of economic slackening. 
                                                
16 Prominence for mothers’ role is found in Knowles et al. (2002) for education. The idea is developed with 
an African proverb in the beginning of the paper trying to emphasize that while educating a man is the same 
as educating one person, educating when we educate a woman we are educating a whole community. 
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6. Conclusion 
Recent decades have witnessed huge improvements in vaccination, infectious 
diseases treatments and access to medical care throughout the world. Nowadays, people are 
able to live longer than ever expected, and with better quality of life. In this work we revisit 
the role of health human capital on economic growth by applying a quantile regression 
approach that allow us to identify different signs and magnitudes for the influence of various 
health proxies across the distribution of the growth rate of output. This can lead to more 
specific policy implications regarding health determinants of economic growth, in particular 
in what concerns health funding by the governments according to economic growth 
performance. For this purpose, we considered a sample of 92 countries over the period 1980-
2010 and applied the quantile techniques proposed by Canay (2011) that allows us to apply 
quantile regression to panel data. 
Our findings suggest that the location on the output growth rate distribution matters 
in terms of the magnitude of the influence of health on macroeconomic performance in the 
long run. The evidence that we present considering different health human capital proxies 
endorses investing in health as a means of improving the growth performance of the 92 
countries in our sample. However, countries will benefit more from health investments when 
they are undergoing periods of growth slowdowns, that is health variables impact is higher 
for countries performing in the lower quantiles of the growth rate distribution. Also, it stands 
out the multifaceted aspects of health. Firstly, infants’ as well as adults’ health status have a 
prominent effect in explaining income per capita growth. On the other hand, despite some 
uncertainty on how it works, there is evidence supporting distinction in the contribution of a 
mother’s health from the males’. 
In summary, we found evidence of parameter heterogeneity regarding health variables 
across quantiles in the sense that the size of the parameters of the health variables found to 
be statistically significant across quantiles with the expected sign, life expectancy, infant 
mortality rate and prevalence of undernourishment varies across quantiles. These results lead 
to different policy implications for over-achieving versus under-performing countries. For 
under achievers (those located at the higher growth quantiles), over the period under analysis 
better health status predicts higher economic growth. For policies concerns, this represents 
an alert for countries undergoing slow growth because investing in health fosters growth. 
Even if those slow growers have enormous levels of health and hardly expect to increase for 
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example their life expectancy to 100 years, it is important for them not to overlook health 
improvements because neglecting this can very well mean negative repercussions on long 
run growth rates. So, especially in times of fiscal constraints health should be an element 
carefully considered. 
We view our results as a starting point to further studies that shed some light on the 
mixed answers provided so far. While we have shown that there is evidence of parameter 
heterogeneity in the health-growth relationship in our sample over the period under analysis, 
further research is needed to understand why such parameter heterogeneity exists. Although 
quantile regressions identify differences between the behaviour of successful vs. less 
successful countries, they do not address the question of why some have been more 
successful than others. 
Additionally, future research should explore other mechanisms of transmission from 
health to economic growth beyond its direct impact on labour productivity in order to 
provide a more complete picture in terms of direct and indirect effects. Forthcoming research 
should also focus on developing consistently over time, for a broad variety of countries, a 
more complete database containing indicators encompassing health dimensions. This way a 
more complete knowledge and understanding of possible improvements in health and its 
repercussions on a country’s income level will be provided. 
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 Appendix 
Appendix I  
From PWT and WDI we collected annual data that we used to assemble the initial 
level of output per capita, education and health in a 5-year period as well as to calculate the 
average level for the 5-year period, regarding the rest of the variables (see table B.2). 
Nevertheless, data on population growth, prevalence of undernourishment and 
consumption of calories per person per day were lacking a few observations for the period 
1980-2010. With the purpose of having a balanced panel model we applied a manipulation 
technique to the annual data of these variables with the use of R programing. Country by 
country, with the use of sas R package, we applied the method updated by Levinson-Durbin 
recursion (Brockwell & Davis 1991, p. 242) to fit to each country an autoregressive model. 
We chose the order of the process that better fitted the data by minimizing Akaike 
information criteria (AIC). After selecting the model, the values for the missing observations 
were estimated and we eventually added them to the data set. 
In order to study long-term relations, we then for periods of 5-years calculated with 
the help of R tools the average growth rates of population and real GDP growth; the average 
of the share of physical capital, the share of government consumption and the share of trade 
in GDP. For human capital and health, we used the initial levels for the period. 
 
Appendix II 
With the purpose of eliminating the hypothesis of spurious estimations we apply 
the Levin-Lin-Chu test (Levin et al. 2002) in GRETL to our panel variables and estimation 
residuals. 
This test assumes cross-sectional independence and a common autoregressive 
parameter for all panels. Therefore, it suggests the following hypothesis: åK: each panel 
contains a unit root; åç: each panel is stationary. Thus, the test does not allow for the 
possibility that some countries contain unit roots while others do not. If the null hypothesis 
is rejected, we are able to conclude that it is stationary. This test is appropriate to apply to 
panel data, however does not suit well, according to Levin et al. (2002), for time periods 
inferior to 5, which is the case of ilgh, under and ilkcal which have 3 and 4 time observations 
for each country. S, for these variables we were not able to compute the test.
 Annexes 
Annex A 
Table A. 1. Summary of selected empirical studies on the effect of health on economic growth 
Study Health measure (in logs) Dependent variable Data Estimator Other covariates 
Main result(s) on the growth 
impact of health 
Acemoglu 
& Johnson 
(2007) 
Life expectancy growth 
Per capita 
output 
growth 
40-year panel, 
1940-1980, n=47 
2SLS 
IV (disease 
mortality 
and global 
intervention 
dates) 
Postyear dummy x institutions or 
postyear dummy x initial log 
GDP 
Negative impact due to Malthusian 
effect. Health impacts population 
negatively and population impact 
economic growth negatively.  
Aghion et 
al. (2011) 
Log life expectancy 
growth, initial level of log 
life expectancy 
Annual per 
capita 
output 
growth rate 
40-year cross-
country, 
1960-2000, n=96 
(LMW) 
IV (LMW 
and/or ME) 
OLS 
Bayesian 
Initial log per capita GDP, 
democracy index, urbanization 
rate, population density, 
openness, log of population, log 
of population x openness 
Positive impact on growth rates. 
Health facilitates growth through 
investment in physical capital and 
fertility rates. 
Bhargava 
et al. 
(2001) 
Adult survival rate, ASR x 
log(GDP) 
Per capita 
GDP 
growth 
rates 
25-year panel at 5-
year interval, 
1965-1990, n=92 
IV 
(Dynamic 
random 
effects) 
Log GDP lagged 5 years, log 
fertility lagged 5 years, Log 
(Investment/GDP), tropics, 
openess 
Positive on low income countries. 
Negative on high income countries. 
Threshold in health-growth relation 
significance reached earlier by low 
income countries. 
Bloom et 
al. (2004) Life expectancy 
Output 
growth rate 
30-year panel data, 
at 10-year interval, 
1960-1990, n=104 
instrument 
(logs) 
Nonlinear 
2SLS 
Barro and Lee (2000) average 
years of schooling, average work 
experience, tropical area, 
governance, investment, active 
population 
Positive and significant through 
health growth and facilitation of 
technology innovation and 
diffusion. 
 Study Health measure (in logs) Dependent variable Data Estimator Other covariates 
Main result(s) on the growth 
impact of health 
Cooray 
(2013) 
Life expectancy by gender 
Survival rates to 65 years 
by gender 
(with and without 
interaction terms with 
fertility rates, health 
expenditure per capita and 
enrolment ratio by gender) 
Output 
growth rate 
18-year panel data, 
1990-2008, n=210 
divided by level of 
income definition 
OLS 
GMM 
Log initial level income per 
capita, investment  in % GDP, 
trade ratio, fertility rate, monetary 
aggregate M2, government 
expenditure ratio, enrolment ratio 
by gender 
Health capital affect economic 
growth due to health expenditure 
and education.  
Positive effect on upper middle and 
high income countries. Negative on 
low and low middle income 
economies. 
Eggoh et 
al. (2015) 
Public expenditure on 
health 
Life expectancy 
Survival rate 
Output 
growth rate 
14-year panel data, 
1996-2010, n=49, 
African countries 
OLS 
GMM 
Log initial level of income, 
education public expenditure, 
school enrolment in primary and 
secondary sector, time dummies, 
inflation rate, net inflows ratio, 
money and quasi money ratio, 
government expenditure ratio 
(health and education excluded), 
ratio of exports plus imports 
Negative impact of health 
expenditure. Positive impact of 
health human capital. 
Positive health-education 
interaction. Threshold in health due 
to education expenditure and vice-
versa. 
Lorentzen 
et al. 
(2008) 
Adult and infant mortality 
rates 
Per capita 
output 
growth 
40-year panel, 
1960-2000, n=96 
OLS 
IV (average 
child and 
adult 
mortality 
rates) 
Initial log per capita GDP, 
Fertility rate, investment share of 
GDP, secondary school ratio, 
Sub-Saharan Africa dummy, 
openness, log population, log 
population x openness, 
government consumption in % of 
GDP 
High mortality inhibits growth to 
escape from poverty trap 
Physical capital and fertility 
facilitate health impact on growth. 
Health-income relation is positive. 
Poças 
(2012) 
Life expectancy 
Infant mortality rate 
CVA mortality rate 
Cancer mortality rate 
Average length of stay 
Available physicians 
Acute care beds 
Health expenditure 
Annual 
average 
output 
growth rate 
24-year panel data 
at 5-year interval, 
1980-2004, 
n=22 
OECD countries 
GMM, 
simultaneous 
equations 
Log initial level income per 
capita, investment in % GDP, 
number of patents, population 
growth 
Positive. 
More significant health predictors: 
CVA mortality and number of 
physicians 
 
 Source: Authors. 
 
Study Health measure (in logs) Dependent variable Data Estimator Other covariates 
Main result(s) on the growth 
impact of health 
Soukiazis 
& Cravo 
(2007) 
Life expectancy, infant 
mortality rate 
Average 
output 
growth rate 
20-year panel data 
at 5-year interval, 
1980-2000, n=77, 
divided by level of 
income definition 
GMM 
(Barro and Lee 2000) average 
years of schooling, publication 
ratio of articles published, patents 
% of population over age 25 ratio, 
growth rate of working age 
population, investment % GDP 
Positive for low income countries. 
Insignificant for high income 
countries. 
Wang 
(2011) 
International health 
expenditure 
Annual 
output 
growth rate 
21-year panel data, 
1986-2007, n=31 
Quantile 
regression - 
Lower tail and upper tail show 
opposite sign. 
Positive in mean and high upper 
tail. 
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Figure B. 1. Scatterplot of average GDP per capita growth rates for period 1980-
1995 and 1995-2010 (92 countries) 
Source: R software output based on author’s calculations. 
 
Figure B. 2. Density function of average per capita growth rate conditioned by the 
time period (92 countries for 1980-2010) 
Source: R software output. 
 
  Figure B. 3. Matrix of health variables interrelationships (scatter plots) 
Source: R software output. 
 
 
Table B. 1. List of countries included in our broader sample’s data set 
Countries 
Albania 
Argentina 
Australia 
Austria 
Bahrain 
Bangladesh 
Belgium 
Benin 
Bolivia 
Botswana 
Brazil 
Bulgaria 
Burundi 
Cambodia 
Cameroon 
Canada 
Chile 
China 
Colombia 
Costa Rica 
Cote d'Ivoire 
Denmark 
Dominican 
Republic 
Egypt 
El Salvador 
Finland 
France 
Gabon 
Gambia 
Germany 
Ghana 
Greece 
Guatemala 
Honduras 
Hungary 
India 
Indonesia 
Ireland 
Israel 
Italy 
Jamaica 
Japan 
Jordan 
Kenya 
Laos 
Lesotho 
Liberia 
Malawi 
Malaysia 
Mali 
Mauritania 
Mauritius 
Mexico 
Mongolia 
Morocco 
Mozambique 
Namibia 
Nepal 
Netherlands 
New Zealand 
Niger 
Norway 
Pakistan 
Panama 
Paraguay 
Peru 
Philippines 
Poland 
Portugal 
Rwanda 
Senegal 
Sierra Leone 
Singapore 
South Africa 
Spain 
Sudan 
Swaziland 
Sweden 
Switzerland 
Tanzania 
Thailand 
Togo 
Trinidad and 
Tobago 
Tunisia 
Turkey 
Uganda 
United Kingdom 
United States 
Uruguay 
Vietnam 
Zambia 
Zimbabwe 
 
Source: Authors’ edit. 
 
  
 Table B. 2. List of variables of our data set 
Notation Description Source Source’s notation 
∆"# Average real GDP per capita growth (calculated the average growth rate of real GDP per capita at chained 
PPPs divided by total population) 
PWT 8.0 rgdpo; pop 
"# Initial level of real GDP per capita PPP’s logarithm (calculated dividing real GDP in million 2005 USD by 
total population in millions) 
PWT 8.0 rgdpo; pop $%&% Average share of physical capital’s stock in GDP PWT 8.0 ck ' Population growth rate World 
Bank 
SP.POP.GROW "()*' Trade (exports plus imports) as a percentage of GDP PWT 7.1 openk $ Share of government consumption in GDP at current 
PPP 
PWT 8.0 csh_g *+,& Barro & Lee (2010) average years of total schooling 
of people aged over 25 
Barro and 
Lee (2010) 
yr_sch 
-"$ℎ Public health expenditure per capita (calculated multiplying total health expenditure per capita by 
public health expenditure as a share of total health) 
World 
Bank 
SH.XPD.PCAP.PP.KD 
SH.XPD.PUBL -""* The inverse of  the logarithm of life expectancy at 
birth in total years’ initial level 
World 
Bank 
SP.DYN.LE00.IN -/0 Initial level of the share of infants dying before 
reaching one year of age 
World 
Bank 
SP.DYN.IMRT.IN 120./ Initial level of the share of male new-born infants that 
would survive to age 65 
World 
Bank 
SP.DYN.TO65.MA.ZS 120. % Initial level of the share of female new-born that 
would survive to age 65 
World 
Bank 
SP.DYN.TO65.FE.ZS 1/0./ Probability of a 15-year old male dying before 
reaching age 60 at the beginning of the period 
World 
Bank 
SP.DYN.AMRT.MA 1/0. % Probability of a 15-year old female dying before 
reaching age 60 at the beginning of the period 
World 
Bank 
SP.DYN.AMRT.FE -"4&1" Inverse of number of calories consumed per day per 
person’s logarithm 
World 
Bank 
SN.ITK.DFCT ,'+*0 Prevalence of undernourishment in population World 
Bank 
SN.ITK.DEFC.ZS 
Source: Databases. Authors’ edit. 
  
 Table B. 3. Health variables’ correlation matrix (58 countries 1995-2010) 
 5667 5689:6 :;<.= :;<. > :=<.= :=<. > 5=< ?@A7< 56BC 5667	 1.00 -0.58 0.97 0.99 -0.91 -0.97 -0.93 -0.61 0.68 5689:6 -0.58 1.00 -0.58 -0.59 0.56 0.58 0.60 0.99 -0.62 :;<.= 0.97 -0.58 1.00 0.96 -0.97 -0.96 -0.86 -0.61 0.59 :;<. > 0.99 -0.59 0.96 1.00 -0.91 -0.99 -0.90 -0.61 0.65 :=<.= -0.91 0.56 -0.97 -0.91 1.00 0.93 0.75 0.58 -0.49 :=<. > -0.97 0.58 -0.96 -0.99 0.93 1.00 0.86 0.61 -0.60 5=< -0.93 0.60 -0.86 -0.90 0.75 0.86 1.00 0.64 -0.80 ?@A7< -0.61 0.99 -0.61 -0.61 0.58 0.61 0.64 1.00 -0.63 56BC 0.68 -0.62 0.59 0.65 -0.49 -0.60 -0.80 -0.63 1.00 
Source: Authors’ calculations with help of R software. 
Annex C 
Table C. 1. Quantile regression estimation results with Life expectancy as the main 
health related explanatory variable (1980-2010 for 92 countries) 
Source: Authors’ calculations with help of R software. 
Notes: lile - life expectancy; liy - initial level of adult male survival rate; yr_sch- initial level of adult female 
survival rate; n - initial level of public health expenditure per capita;	gfcf - initial level of consumption of 
calories per day per person;	open - share of trade in output; g - share of government consumption in output; 
Standard errors in parenthesis. For equality slope test is presented the test’s statistic and in parenthesis the p-
value. ***, **, * and ‘.’ denote the statistical significance at the 0.1%, 1%, 5% and 10% levels, respectively.
 FE 
Quantile Equality 
test S = 0.05 S = 0.25 S = 0.5 S = 0.75 S = 0.95 
Int.  
1.0694*** 1.1161*** 0.9658*** 0.8796*** 0.9196***  
(0.1203) (0.1116) (0.0893) (0.0876) (0.1967)  5667 0.1179*** -1.7878*** -1.9006*** -1.2211*** -0.9630** -0.8711 2.9263 
(0.0312) (0.3737) (0.3693) (0.3199) (0.3047) (0.7011) (0.0198)* 6T -0.0947*** -0.0975*** -0.0947*** -0.0953*** -0.0921*** -0.0997*** 1.0509 
(0.0067) (0.0362) (0.0030) (0.0017) (0.0027) (0.0061) (0.3793) 7A?9 0.035*** 0.0157*** 0.0123*** 0.0135*** 0.0118*** 0.0132*** 3.6312 
(0.0019) (0.0018) (0.0010) (0.0008) (0.0009) (0.0021) (0.0058)** @ 0.4719** 0.5397 . 0.2919 . 0.2255 0.1770 0.0774 0.3536 
(0.1791) (0.2770) (0.1507) (0.1561) (0.1971) (0.5229) (0.8416) B>9> -0.0090*** -0.0065 -0.0093*** -0.0108*** -0.0096*** -0.0085* 0.7577 
(0.0020) (0.0049) (0.0015) (0.0015) (0.0017) (0.0034) (0.5537) 6UV7@ 0.0225*** 0.0196*** 0.0207*** 0.0218*** 0.0258*** 0.0281*** 1.6778 
(0.0057) (0.0048) (0.0026) (0.0017) (0.0027) (0.0048) (0.1522) B 0.0110 -0.0283 -0.0121 -0.0195 0.0111 0.0603 1.0396 
(0.0110) (0.0362) (0.0150) (0.0213) (0.0251) (0.0611) (0.3851) 
  
